Abstract
Regardless of its origin, any condition associated with inflammation is accompanied by an increase in serum C-reactive protein levels. This study compared the results of a rapid test for the bedside assay of C-reactive protein (QuikRead CRP, Orion Corporation, Orion Diagnostica, Espoo, Finland) with those of a standard laboratory assay in samples taken from 231 children aged less than 14years (126 males; median age 4.7years) attending the Emergency Department of Milan University's Institute of Pediatrics because of acute respiratory infection. The two methods showed similar median C-reactive protein levels (standard laboratory assay: 34.7mg/L, range 4–199mg/L; QuikRead CRP: 33.3mg/L, range <8–196mg/L; p=0.779) and a similar distribution of children with C-reactive protein levels of <20mg/L, 20–70mg/L and >70mg/L. This study shows for the first time that the rapid QuikRead CRP test can be performed at the bedside or in an outpatient clinic and, in less than 5min, gives the same quantitative results as those obtained using a more complex routine laboratory method.
References
1 Korppi M, Heiskanen-Kosma T, Leinonen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J 1997; 10: 1125–9. 10.1183/09031936.97.10051125Search in Google Scholar
2 Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36months of age with clinically undetectable serious bacterial infection. Pediatrics 2001; 108: 1275–9. 10.1542/peds.108.6.1275Search in Google Scholar
3 Lambert M, Delvin EE, Paradis G, O'Loughlin J, Hanley JA, Levy E. C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem 2004; 50: 1762–8. 10.1373/clinchem.2004.036418Search in Google Scholar
4 Philip AG, Mills PC. Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics 2000; 106: E4. 10.1542/peds.106.1.e4Search in Google Scholar
5 Pettila V, Pentti J, Pettila M, Takkunen O, Jousela I. Predictive value of antithrombin III and serum C-reactive protein concentration in critically ill patients with suspected sepsis. Crit Care Med 2002; 30: 271–5. 10.1097/00003246-200202000-00001Search in Google Scholar
6 Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363–9. 10.1161/01.CIR.0000053730.47739.3CSearch in Google Scholar
7 Rothenburger M, Markewitz A, Lenz T, Kaulbach HG, Marohl K, Kuhlmann WD, et al. Detection of acute phase response and infection: the role of procalcitonin and C-reactive protein. Clin Chem Lab Med 1999; 37: 275–9. 10.1515/CCLM.1999.048Search in Google Scholar
8 Gervaix A, Galetto-Lacour A, Gueron T, Vadas L, Zamora S, Suter S, et al. Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr Infect Dis J 2001; 20: 507–11. 10.1097/00006454-200105000-00007Search in Google Scholar
9 Boeken U, Feindt P, Zimmermann N, Kalweit G, Petzold T, Gams E. Increased preoperative C-reactive protein (CRP)-values without signs of an infection and complicated course after cardiopulmonary bypass (CBP)-operations. Eur J Cardiothorac Surg 1998; 13: 541–5. 10.1016/S1010-7940(98)00062-1Search in Google Scholar
10 Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24: 185–8. 10.1007/s001340050543Search in Google Scholar PubMed
11 Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206–17. 10.1086/421997Search in Google Scholar
12 Urbach J, Shapira I, Branski D, Berliner S. Acute phase response in the diagnosis of bacterial infections in children. Pediatr Infect Dis J 2004; 23: 159–60. 10.1097/01.inf.0000115735.78960.a4Search in Google Scholar
13 Prat C, Dominguez J, Rodrigo C, Gimenez M, Azuara M, Jimenez O, et al. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J 2003; 22: 963–8. 10.1097/01.inf.0000095197.72976.4fSearch in Google Scholar
14 Galetto-Macour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003; 112: 1054–60. 10.1542/peds.112.5.1054Search in Google Scholar
15 Van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004; 4: 620–30. 10.1016/S1473-3099(04)01146-6Search in Google Scholar
16 World Health Organization (WHO). WHO report on infectious disease: overcoming antimicrobial resistance. Geneva: WHO, 2000. Search in Google Scholar
17 Wang EE, Einarson TR, Kellner JD, Conly JM. Antibiotic prescribing for Canadian preschool children: evidence of overprescribing for viral respiratory infections. Clin Infect Dis 1999; 29: 155–60. 10.1086/520145Search in Google Scholar PubMed
18 Esposito S, Blasi F, Allegra L, Principi N, the Mowgli Study Group. The use of antimicrobials for community-acquired lower respiratory tract infections in hospitalized children. Eur J Clin Microbiol Infect Dis 2001; 20: 647–50. 10.1007/s100960100570Search in Google Scholar PubMed
19 Esposito S, Marchisio P, Morelli P, Crovari P, Principi N. Effect of a rapid influenza diagnosis. Arch Dis Child 2003; 88: 525–6. 10.1136/adc.88.6.525Search in Google Scholar PubMed PubMed Central
20 Virkki R, Juven T, Rihalainen H, Svedstrom E, Mertsola J, Ruuskanen O. Differentiation of bacterial and viral pneumonia in children. Thorax 2002; 57: 438–41. 10.1136/thorax.57.5.438Search in Google Scholar PubMed PubMed Central
21 Principi N, Esposito S. Paediatric community-acquired pneumonia: current concept in pharmacological control. Expert Opin Pharmacother 2003; 4: 761–77. 10.1517/14656566.4.5.761Search in Google Scholar PubMed
© by Walter de Gruyter Berlin New York
